Hypertension (high blood pressure) Board decisions

The Veteran's hypertension is granted as due to herbicide exposure under the PACT Act. The direct service connection claim for hypertension remains pending and will be remanded.

The Veteran's TDIU claim was granted in a November 2023 rating decision, effective May 11, 2022. The appeal for this issue is dismissed as the award has already been made.

The Veteran withdrew his appeals regarding hypertension and chronic kidney disease, leading to their dismissal.

The Veteran's hypertension, which required continuous medication for control, was rated at a minimum of 10 percent throughout the appeal period.

The Board has denied service connection for COPD, diabetes mellitus, left shoulder joint pain, right shoulder joint pain, and hypertension/vasovagal syndrome. The remaining issues have been remanded due to the need for additional medical examinations.

The Veteran's claim for a compensable rating for hypertension has been denied.,The Veteran's claim for service connection for dyslexia is remanded and will be adjudicated again.

The Veteran's service connection for anxiety and hypertension is granted. However, the rating for hypertension remains denied, and a remand is ordered to determine the appropriate rating for his lumbar spine condition.

The Board has remanded the claims for hypertension, heart disorder, and GERD due to inadequate opinions in previous VA examinations. The Veteran is seeking service connection for these conditions based on in-service cold weather injuries.

The Board has decided to remand the case due to the Veteran's failure to appear for a VA examination and because of the need to obtain a medical opinion regarding the relationship between the Veteran's hypertension and service, including his in-service exposure to toxins. The case will be returned to the AOJ for further development.

The Board has found that the Veteran's service-connected disabilities do not preclude him from working, but additional evidence is needed to determine his ability to maintain gainful employment due to these conditions.

The Board granted service connection for hypertension, resolving the benefit of the doubt in favor of the Veteran.

The Veteran's appeal for a compensable rating for hypertension has been dismissed as the Veteran withdrew the appeal before any decision was made.

The Board denied service connection for hypertension, finding that the evidence did not support a claim of exposure to herbicides during the Veteran's active duty in Panama.

The Board has determined that the Veteran does not have a psychiatric disability other than PTSD, and his GERD and hypertension claims are remanded for further development.,The Veteran's PTSD is currently rated at 70% since December 8, 2023. The Board found no evidence of higher ratings prior to March 18, 2022.

The Board has granted an effective date of April 22, 2019 for the award of service connection for hypertension due to herbicide agent exposure on a direct basis. The issue of entitlement to an initial compensable rating for hypertension is also remanded.

The Veteran's hearing loss is not service-connected due to lack of a current diagnosis.,PTSD symptoms do not meet the criteria for a 100% disability rating, but are sufficient for a 70% disability rating.

The Board has decided that the Veteran's claim of service connection for hypertension secondary to PTSD should be remanded due to insufficient evidence. The examiner is required to provide an opinion on whether the hypertension is caused by a service-connected disability or aggravated by a service-connected disability.

The Veteran's claims for service connection have been dismissed as the evidence does not support a finding of in-service onset or continuity of symptoms for any of the claimed conditions.

The Board denied service connection for hypertension as there is no current diagnosis of the condition.

The Veteran's appeals for diabetes mellitus, hypertension, and prostate cancer have been withdrawn. The claims of service connection for residuals of prostate cancer, lung disability (IPF), kidney disease, and IBS are remanded due to new evidence submitted after the prior final rating decisions.